These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30918097)

  • 1. Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.
    Glaze DG; Neul JL; Kaufmann WE; Berry-Kravis E; Condon S; Stoms G; Oosterholt S; Della Pasqua O; Glass L; Jones NE; Percy AK;
    Neurology; 2019 Apr; 92(16):e1912-e1925. PubMed ID: 30918097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome.
    Neul JL; Percy AK; Benke TA; Berry-Kravis EM; Glaze DG; Peters SU; Jones NE; Youakim JM
    Contemp Clin Trials; 2022 Mar; 114():106704. PubMed ID: 35149233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.
    Glaze DG; Neul JL; Percy A; Feyma T; Beisang A; Yaroshinsky A; Stoms G; Zuchero D; Horrigan J; Glass L; Jones NE
    Pediatr Neurol; 2017 Nov; 76():37-46. PubMed ID: 28964591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure-Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome.
    Darwish M; Passarell J; Youakim JM; Bradley H; Bishop KM
    Adv Ther; 2024 Apr; 41(4):1462-1480. PubMed ID: 38363467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome.
    Berry-Kravis E; Horrigan JP; Tartaglia N; Hagerman R; Kolevzon A; Erickson CA; Hatti S; Snape M; Yaroshinsky A; Stoms G; ; Glass L; Jones NE
    Pediatr Neurol; 2020 Sep; 110():30-41. PubMed ID: 32660869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is trofinetide a future treatment for Rett syndrome? A comprehensive systematic review and meta-analysis of randomized controlled trials.
    Mohammed HE; Bady Z; Haseeb ME; Aboeldahab H; Sharaf-Eldin WE; Zaki MS
    BMC Med; 2024 Jul; 22(1):299. PubMed ID: 39020317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome.
    Neul JL; Percy AK; Benke TA; Berry-Kravis EM; Glaze DG; Peters SU; Marsh ED; An D; Bishop KM; Youakim JM
    Pediatr Neurol; 2024 Mar; 152():63-72. PubMed ID: 38232652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.
    Neul JL; Percy AK; Benke TA; Berry-Kravis EM; Glaze DG; Marsh ED; Lin T; Stankovic S; Bishop KM; Youakim JM
    Nat Med; 2023 Jun; 29(6):1468-1475. PubMed ID: 37291210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives.
    Moore R; Poulsen J; Reardon L; Samples-Morris C; Simmons H; Ramsey KM; Whatley ML; Lane JB
    Adv Ther; 2024 Apr; 41(4):1305-1317. PubMed ID: 38378975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study.
    Percy AK; Neul JL; Benke TA; Berry-Kravis EM; Glaze DG; Marsh ED; Barrett AM; An D; Bishop KM; Youakim JM
    Med; 2024 Jul; ():. PubMed ID: 39025065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of the efficacy and safety of trofinetide in patients with rett syndrome.
    Abo Zeid M; Elrosasy A; Mohamed RG; Ghazou A; Goufa E; Hassan N; Abuzaid Y
    Neurol Sci; 2024 May; ():. PubMed ID: 38771525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the Rett Syndrome Behaviour Questionnaire and its utilization in the assessment of symptoms associated with Rett syndrome.
    Percy AK; Neul JL; Benke TA; Marsh ED; Glaze DG
    Front Pediatr; 2023; 11():1229553. PubMed ID: 37635789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of creatine supplementation in Rett syndrome: a randomized, placebo-controlled trial.
    Freilinger M; Dunkler D; Lanator I; Item CB; Mühl A; Fowler B; Bodamer OA
    J Dev Behav Pediatr; 2011; 32(6):454-60. PubMed ID: 21654506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study.
    Percy AK; Neul JL; Benke TA; Berry-Kravis EM; Glaze DG; Marsh ED; An D; Bishop KM; Youakim JM
    Med; 2024 Jun; ():. PubMed ID: 38917793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trofinetide in Rett syndrome: A brief review of safety and efficacy.
    Singh A; Balasundaram MK; Gupta D
    Intractable Rare Dis Res; 2023 Nov; 12(4):262-266. PubMed ID: 38024580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome.
    Motil KJ; Beisang A; Smith-Hicks C; Lembo A; Standridge SM; Liu E
    Expert Rev Gastroenterol Hepatol; 2024 Jun; 18(6):227-237. PubMed ID: 38869952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of trofinetide in Rett syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Abbas A; Fayoud AM; El Din Moawad MH; Hamad AA; Hamouda H; Fouad EA
    BMC Pediatr; 2024 Mar; 24(1):206. PubMed ID: 38521908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need.
    Hudu SA; Elmigdadi F; Qtaitat AA; Almehmadi M; Alsaiari AA; Allahyani M; Aljuaid A; Salih M; Alghamdi A; Alrofaidi MA; Abida ; Imran M
    J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trofinetide-a new chapter in rett syndrome's treatment.
    Furqan M
    Front Pharmacol; 2023; 14():1284035. PubMed ID: 38035006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trofinetide (Daybue) for Rett syndrome.
    Med Lett Drugs Ther; 2024 Jul; 66(1706):e115-e116. PubMed ID: 38981105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.